A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD1705 in participants with dyslipidemia

Trial Identifier: D7650C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: January 2024
Primary Completion Date: December 2025
Study Completion Date: December 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations